# Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass

> **NCT01002859** · PHASE2 · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 50 (actual)

## Conditions studied

- Coronary Artery Bypass Surgery
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** Sandimmum
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01002859
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2011-05
- **Final completion:** 2011-07
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** difficulties to include patients
- **Last updated:** 2014-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002859, "Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01002859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*